NASDAQ:CODX
Company-Diagnostics Inc Stock News
$1.11
-0.120 (-9.76%)
At Close: May 10, 2024
Co-Diagnostics adds four new experts to its Scientific Advisory Board
11:06am, Thursday, 17'th Mar 2022
Co-Diagnostics (NASDAQ:CODX) Inc has beefed up its Scientific Advisory Board with the addition of four new experts. The molecular diagnostics company is welcoming Idaho Technology/BioFire CSO Carl Wit
CoDiagnostics, Inc. (CODX) Surges 13.1%: Is This an Indication of Further Gains?
06:30am, Wednesday, 16'th Mar 2022 Zacks Investment Research
CoDiagnostics, Inc. (CODX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price
CoDiagnostics, Inc. (CODX) Surges 13.1%: Is This an Indication of Further Gains?
03:46am, Wednesday, 16'th Mar 2022
CoDiagnostics, Inc. (CODX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price
Why Co-Diagnostics Is Soaring Today
05:15pm, Tuesday, 15'th Mar 2022 The Motley Fool
The diagnostics and research outfit gave investors a dose of good news today.
Co-Diagnostics announces $30M buyback program (NASDAQ:CODX)
01:36pm, Tuesday, 15'th Mar 2022 Seeking Alpha
Co-Diagnostics <> has received Board''s approval to repurchase up to $30M of its common share under the new buyback program. "This share repurchase program is aligned with…
Why Co-Diagnostics Is Soaring Today
01:15pm, Tuesday, 15'th Mar 2022
The diagnostics and research outfit gave investors a dose of good news today.
Why Co-Diagnostics Shares Are Trading Higher Today
11:16am, Tuesday, 15'th Mar 2022
Co-Diagnostics Inc (NASDAQ: CODX) shares are trading higher Tuesday after the company announced its board authorized a share repurchase program, allowing Co-Diagnostics to repurchase up to $30 mil
Biodesix, Inc. (BDSX) Reports Q4 Loss, Lags Revenue Estimates
11:15am, Monday, 14'th Mar 2022 Zacks Investment Research
Biodesix, Inc. (BDSX) delivered earnings and revenue surprises of 2% and 1.45%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
CO-DIAGNOSTICS, INC. ANNOUNCES FOURTH QUARTER AND FULL YEAR 2021 EARNINGS RELEASE DATE AND WEBCAST
09:30am, Monday, 14'th Mar 2022
SALT LAKE CITY , March 14, 2022 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests
Strength Seen in Assure Holdings Corp. (IONM): Can Its 7.3% Jump Turn into More Strength?
12:16pm, Thursday, 10'th Mar 2022 Zacks Investment Research
Assure Holdings Corp. (IONM) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strengt
Co-Diagnostics announces approval for Hep B test in India (NASDAQ:CODX)
04:28pm, Thursday, 03'rd Feb 2022 Seeking Alpha
Co-Diagnostics (CODX) announced its joint venture in India, CoSara Diagnostics, received clearance from the regulatory authorities to manufacture and sell SARAQ Hepatitis B ((HBV))
Co-Diagnostics says its joint venture CoSara receives clearance from Indian regulators from Hepatitis B viral load test
11:20am, Thursday, 03'rd Feb 2022
Co-Diagnostics (NASDAQ:CODX) Inc announced that CoSara Diagnostics Private Ltd, its joint venture for manufacturing and sales in India, has received clearance by the Central Drugs Standard Control Or
Co-Diagnostics: Swinging For The Fences
08:19am, Monday, 24'th Jan 2022
Seeking Alpha's three ratings metrics have long awarded Co-Diagnostics top grades of "A+".
Should Value Investors Buy These Medical Stocks?
02:40pm, Thursday, 06'th Jan 2022 Zacks Investment Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Has CoDiagnostics, Inc. (CODX) Outpaced Other Medical Stocks This Year?
02:40pm, Wednesday, 05'th Jan 2022 Zacks Investment Research
Here is how CoDiagnostics, Inc. (CODX) and Cronos Group (CRON) have performed compared to their sector so far this year.
